JULIA CAMARGO: Open Payments
NPI 1518466424 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 75 payments from 21 companies in 2025. Trend: 2023 $1,218 · 2024 $1,689 · 2025 $1,834
Food & beverage: $1,834
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $475 |
| ABBVIE INC. | 12 | $235 |
| PFIZER INC. | 8 | $162 |
| Lilly USA, LLC | 5 | $114 |
| Noah Medical Corporation | 1 | $107 |
| HARMONY BIOSCIENCES LLC | 3 | $106 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
| Exact Sciences Corporation | 2 | $57 |
Products named: Wegovy, Rybelsus, UBRELVY, GALAXY, WAKIX, QULIPTA, PREVNAR 20, MOUNJARO.
Industry payments across VA — which companies pay providers there.
